More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.

A bill introduced by Rep. Buddy Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

CVS CEO Larry Menlo said the company will make $300 million this year, and Cigna disclosed that Express Scripts makes $400 million. CVS, Express Scripts provide a rare moment of transparency on ...

CVS Health, Cigna and UnitedHealth Group are demanding that FTC Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the company ... CVS Health's Caremark, ...

CVS Caremark previously managed Centene's drug spending. Cigna's allegation follows a string of similar cases between healthcare employers, former employees and competitors over noncompete agreements.

CVS Caremark, Cigna's Express Scripts and UnitedHealth Group's OptumRx collectively control about 80% of the PBM market, according to the FTC. Letter. to the. Editor. Send us a letter ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, ... The largest are CVS Caremark; Express Scripts, which is Cigna’s PBM; ...